Review



biofire fa-rp 2.1  (BioFire Defense)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BioFire Defense biofire fa-rp 2.1
    Biofire Fa Rp 2.1, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biofire+fa-rp+2%2E1/biofire+rp2+1/pm37797063-143-10-9
    Average 90 stars, based on 1 article reviews
    biofire fa-rp 2.1 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    MANN-WHITNEY:

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Similarly, among the patients who tested positive for the BioFire FA-RP 2.1, 9 years was the median age (Q1 3 –Q3 14), while those who tested negative had a median age of 4 years (Q1 0.8 –Q3 10); p = 0,001 U (Mann Whitney test).

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Several studies demonstrated the high sensitivity and specificity of BioFire FA-RP 2.1 in the adult population [18, 21–23].

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 detected SARS-CoV-2 infection in 63 out of 339 (18.5%) nasopharyngeal swab samples obtained from the participants.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Our findings demonstrated the high sensitivity of BioFire FA-RP 2.1 for SARS-CoV-2 detection in children, a high positive likelihood ratio (LR+), and excellent agreement with the reference test.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 sensitivity was 95%, the specificity 94%, the positive predictive value 75%, and the negative predictive value 99%.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 automatically identifies the pathogen agent in the clinical sample, yielding immediate results, and boasts a rapid turnaround time of 45 minutes, faster than the conventional methods that can take over 4 hours.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: In addition to the BioFire FA-RP 2.1, several other rapid COVID-19 testing platforms have emerged, including the Cepheid Xpert Xpress SARS-CoV-2 [27], DiaSorin Simplexa [28, 29], and GenMark ePlex SARS-CoV-2 tests [30].

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Here, we present the first prospective evaluation of the BioFire FA-RP 2.1 accuracy for SARS-CoV-2 detection in a pediatric population.

    Infection:

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Similarly, among the patients who tested positive for the BioFire FA-RP 2.1, 9 years was the median age (Q1 3 –Q3 14), while those who tested negative had a median age of 4 years (Q1 0.8 –Q3 10); p = 0,001 U (Mann Whitney test).

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Several studies demonstrated the high sensitivity and specificity of BioFire FA-RP 2.1 in the adult population [18, 21–23].

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 detected SARS-CoV-2 infection in 63 out of 339 (18.5%) nasopharyngeal swab samples obtained from the participants.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Our findings demonstrated the high sensitivity of BioFire FA-RP 2.1 for SARS-CoV-2 detection in children, a high positive likelihood ratio (LR+), and excellent agreement with the reference test.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 sensitivity was 95%, the specificity 94%, the positive predictive value 75%, and the negative predictive value 99%.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 automatically identifies the pathogen agent in the clinical sample, yielding immediate results, and boasts a rapid turnaround time of 45 minutes, faster than the conventional methods that can take over 4 hours.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: In addition to the BioFire FA-RP 2.1, several other rapid COVID-19 testing platforms have emerged, including the Cepheid Xpert Xpress SARS-CoV-2 [27], DiaSorin Simplexa [28, 29], and GenMark ePlex SARS-CoV-2 tests [30].

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Here, we present the first prospective evaluation of the BioFire FA-RP 2.1 accuracy for SARS-CoV-2 detection in a pediatric population.

    Reverse Transcription Polymerase Chain Reaction:

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Similarly, among the patients who tested positive for the BioFire FA-RP 2.1, 9 years was the median age (Q1 3 –Q3 14), while those who tested negative had a median age of 4 years (Q1 0.8 –Q3 10); p = 0,001 U (Mann Whitney test).

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Several studies demonstrated the high sensitivity and specificity of BioFire FA-RP 2.1 in the adult population [18, 21–23].

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 detected SARS-CoV-2 infection in 63 out of 339 (18.5%) nasopharyngeal swab samples obtained from the participants.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Our findings demonstrated the high sensitivity of BioFire FA-RP 2.1 for SARS-CoV-2 detection in children, a high positive likelihood ratio (LR+), and excellent agreement with the reference test.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 sensitivity was 95%, the specificity 94%, the positive predictive value 75%, and the negative predictive value 99%.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 automatically identifies the pathogen agent in the clinical sample, yielding immediate results, and boasts a rapid turnaround time of 45 minutes, faster than the conventional methods that can take over 4 hours.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: In addition to the BioFire FA-RP 2.1, several other rapid COVID-19 testing platforms have emerged, including the Cepheid Xpert Xpress SARS-CoV-2 [27], DiaSorin Simplexa [28, 29], and GenMark ePlex SARS-CoV-2 tests [30].

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Here, we present the first prospective evaluation of the BioFire FA-RP 2.1 accuracy for SARS-CoV-2 detection in a pediatric population.

    Multiplex Assay:

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Similarly, among the patients who tested positive for the BioFire FA-RP 2.1, 9 years was the median age (Q1 3 –Q3 14), while those who tested negative had a median age of 4 years (Q1 0.8 –Q3 10); p = 0,001 U (Mann Whitney test).

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Several studies demonstrated the high sensitivity and specificity of BioFire FA-RP 2.1 in the adult population [18, 21–23].

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 detected SARS-CoV-2 infection in 63 out of 339 (18.5%) nasopharyngeal swab samples obtained from the participants.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Our findings demonstrated the high sensitivity of BioFire FA-RP 2.1 for SARS-CoV-2 detection in children, a high positive likelihood ratio (LR+), and excellent agreement with the reference test.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 sensitivity was 95%, the specificity 94%, the positive predictive value 75%, and the negative predictive value 99%.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 automatically identifies the pathogen agent in the clinical sample, yielding immediate results, and boasts a rapid turnaround time of 45 minutes, faster than the conventional methods that can take over 4 hours.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: In addition to the BioFire FA-RP 2.1, several other rapid COVID-19 testing platforms have emerged, including the Cepheid Xpert Xpress SARS-CoV-2 [27], DiaSorin Simplexa [28, 29], and GenMark ePlex SARS-CoV-2 tests [30].

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Here, we present the first prospective evaluation of the BioFire FA-RP 2.1 accuracy for SARS-CoV-2 detection in a pediatric population.

    Polymerase Chain Reaction:

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Similarly, among the patients who tested positive for the BioFire FA-RP 2.1, 9 years was the median age (Q1 3 –Q3 14), while those who tested negative had a median age of 4 years (Q1 0.8 –Q3 10); p = 0,001 U (Mann Whitney test).

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Several studies demonstrated the high sensitivity and specificity of BioFire FA-RP 2.1 in the adult population [18, 21–23].

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 detected SARS-CoV-2 infection in 63 out of 339 (18.5%) nasopharyngeal swab samples obtained from the participants.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Our findings demonstrated the high sensitivity of BioFire FA-RP 2.1 for SARS-CoV-2 detection in children, a high positive likelihood ratio (LR+), and excellent agreement with the reference test.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 sensitivity was 95%, the specificity 94%, the positive predictive value 75%, and the negative predictive value 99%.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: The BioFire FA-RP 2.1 automatically identifies the pathogen agent in the clinical sample, yielding immediate results, and boasts a rapid turnaround time of 45 minutes, faster than the conventional methods that can take over 4 hours.

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: In addition to the BioFire FA-RP 2.1, several other rapid COVID-19 testing platforms have emerged, including the Cepheid Xpert Xpress SARS-CoV-2 [27], DiaSorin Simplexa [28, 29], and GenMark ePlex SARS-CoV-2 tests [30].

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.
    Article Snippet: Here, we present the first prospective evaluation of the BioFire FA-RP 2.1 accuracy for SARS-CoV-2 detection in a pediatric population.



    Similar Products

    biofire fa-rp 2.1  (BioFire Defense)
    90
    BioFire Defense biofire fa-rp 2.1
    Biofire Fa Rp 2.1, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biofire+fa-rp+2%2E1/biofire+rp2+1/pm37797063-143-10-9
    Average 90 stars, based on 1 article reviews
    biofire fa-rp 2.1 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    multiplex pcr assays biofire fa rp 2.1  (BioFire Defense)
    90
    BioFire Defense multiplex pcr assays biofire fa rp 2.1
    Multiplex Pcr Assays Biofire Fa Rp 2.1, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biofire+fa-rp+2%2E1/biofire+rp2+1/pm37797063-190-8-7
    Average 90 stars, based on 1 article reviews
    multiplex pcr assays biofire fa rp 2.1 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    biofire fa-rp 2.1 panel  (BioFire Diagnostics)
    90
    BioFire Diagnostics biofire fa-rp 2.1 panel
    Performance comparison between the BioFire FA-RP 2.1 and the reference RT-PCR tests according to the patient characteristics (positive testes, n = 111).
    Biofire Fa Rp 2.1 Panel, supplied by BioFire Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biofire+fa-rp+2%2E1/biofire+filmarray+respiratory+panel/pmc10553804-130-7-10
    Average 90 stars, based on 1 article reviews
    biofire fa-rp 2.1 panel - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Journal: PLOS ONE

    Article Title: Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting

    doi: 10.1371/journal.pone.0292314

    Figure Lengend Snippet: Performance comparison between the BioFire FA-RP 2.1 and the reference RT-PCR tests according to the patient characteristics (positive testes, n = 111).

    Article Snippet: To evaluate the accuracy of the BioFire FA-RP 2.1 Panel (BioFire Diagnostics, Salt Lake City, UT, USA), our index test, we utilized the Light Mix Modular SarbeCoV E-gene EAV kit (TIB Molbiol, Berlin, Germany) as the reference test for comparison.

    Techniques: Comparison, Sampling